Epidemiological studies suggest that moderate alcohol consumption increases
the risk of breast cancer, and that alcohol combined with estrogen replace
ment therapy may synergistically enhance the risk, However, the mechanism(s
) of alcohol-induced mammary cancer is unknown. In human breast cancer cell
lines, we found that ethanol (EtOH) caused a dose-dependent increase of up
to 10- to 15-fold in the transcriptional activity of the liganded estrogen
receptor (ER-alpha), but did not activate the nonliganded receptor. Signif
icant stimulation of ER-alpha activity was observed at EtOH concentrations
comparable with or less than blood alcohol levels associated with intoxicat
ion and at doses below the threshold for ill vitro cytotoxicity. These find
ings may be explained, in part, by an EtOH-induced down-regulation of the e
xpression of BRCA1, a potent inhibitor of ER-alpha activity, and, in part,
by a modest increase in the ER-alpha levels. Our findings suggest that inac
tivation of BRCA1 and increased estrogen-responsiveness might contribute to
alcohol-induced breast cancer.